Authors’ reply to Oussedik and colleaguesBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3672 (Published 28 May 2012) Cite this as: BMJ 2012;344:e3672
- Matthew L Costa, professor of trauma and orthopaedic surgery1
- On behalf of Juul Achten, Nick R Parsons, Richard P Edlin, Pedro Foguet, Udai Prakash, Damian R Griffin
- 1Warwick Clinical Trials Unit, Division of Health Sciences, University of Warwick, Coventry CV4 7AL, UK
Oussedik and colleagues make some interesting points about our trial and the place of hip resurfacing in treating patients with severe arthritis.1
The trial involved many surgeons using several different approaches and implants. This was a deliberate policy: a “pragmatic” trial reflects the variety of surgeons, approaches, and implants encountered across the NHS.
Radiographic outcomes and data on metal ions are important factors related …